TELA Bio Inc.

NASDAQ: TELA · Real-Time Price · USD
1.58
-0.02 (-1.25%)
At close: Aug 15, 2025, 3:59 PM
1.58
-0.05%
After-hours: Aug 15, 2025, 04:04 PM EDT

TELA Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
20.2M 18.52M 17.65M 18.96M 16.09M 16.6M 17M 15.05M 14.49M 11.91M 11.62M 11.16M 10.41M 8.23M 8.37M 7.65M 7.56M 5.88M
Cost of Revenue
6.09M 6.01M 6.43M 6.1M 5.02M 5.27M 5.37M 4.66M 4.29M 4.01M 3.45M 3.84M 3.86M 3.23M 2.71M 3.05M 2.47M 2.41M
Gross Profit
14.11M 12.51M 11.22M 12.86M 11.07M 11.34M 11.62M 10.39M 10.2M 7.9M 8.18M 7.32M 6.55M 5M 5.66M 4.6M 5.09M 3.46M
Operating Income
-9.08M -10.47M -8.35M -9.37M -11.57M -12.41M -12.28M -10.18M -10.36M -11.25M -9.44M -9.49M -10.24M -9.84M -7.65M -7.22M -7.31M -7.27M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-9.89M -11.21M -9.35M -10.37M -12.6M -5.66M -12.89M -10.96M -10.79M -12.03M -9.98M -10.71M -12.74M -10.86M -8.62M -8.27M -8.26M -8.14M
Net Income
-9.92M -11.26M -9.21M -10.37M -12.6M -5.66M -12.89M -10.96M -10.79M -14.05M -9.77M -11.94M -13.35M -11.88M -8.62M -8.27M -8.26M -8.14M
Selling & General & Admin
20.98M 20.44M 17.55M 20.16M 20.32M 21.35M 21.22M 18.2M 18.05M 17.1M 14.89M 14.7M 14.69M 12.84M 11.59M 10.41M 10.47M 9.05M
Research & Development
2.2M 2.54M 2.03M 2.07M 2.32M 2.39M 2.69M 2.37M 2.51M 2.05M 2.73M 2.1M 2.1M 2.01M 1.73M 1.41M 1.93M 1.68M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -107K -43K n/a -80K 22K
Operating Expenses
23.19M 22.98M 19.57M 22.22M 22.64M 23.74M 23.9M 20.57M 20.56M 19.15M 17.61M 16.81M 16.79M 14.84M 13.31M 11.82M 12.4M 10.73M
Interest Expense
1.19M 1.22M 1.28M 1.34M 1.33M 1.33M 1.34M 1.33M 1.3M 1.25M 1.17M 1.03M 934K 911K 922K 922K 864K 889K
Selling & Marketing Expenses
16.86M 16.61M 13.96M 16.47M 16.7M 17.52M 17.16M 14.47M 14.58M 13.47M 11.65M 11.17M 11.05M 9.38M 8.31M 6.95M 7.5M 6.3M
Cost & Expenses
29.28M 28.99M 26M 28.32M 27.66M 21.43M 29.28M 25.23M 24.86M 23.16M 21.06M 20.65M 20.64M 18.07M 16.03M 14.87M 14.87M 13.15M
Income Tax Expense
33K 52K -144K n/a n/a n/a n/a n/a n/a 2.02M -207K 1.23M 607K 1.02M n/a n/a n/a n/a
Shares Outstanding (Basic)
45.37M 45.27M 40.07M 24.7M 24.66M 24.58M 24.49M 24.48M 23.24M 19.19M 19.16M 16.76M 14.56M 14.48M 14.51M 14.49M 14.46M 14.44M
Shares Outstanding (Diluted)
45.37M 45.27M 40.07M 24.7M 24.66M 24.58M 24.49M 24.48M 23.24M 19.19M 19.16M 16.76M 14.56M 14.54M 14.51M 14.49M 14.46M 14.44M
EPS (Basic)
-0.22 -0.25 -0.23 -0.42 -0.51 -0.23 -0.53 -0.45 -0.46 -0.73 -0.51 -0.71 -0.92 -0.82 -0.59 -0.57 -0.57 -0.56
EPS (Diluted)
-0.22 -0.25 -0.23 -0.42 -0.51 -0.23 -0.53 -0.45 -0.46 -0.73 -0.51 -0.71 -0.92 -0.82 -0.59 -0.57 -0.57 -0.56
EBITDA
-8.43M -9.73M -7.8M -8.77M -11.02M -4.09M -11.38M -9.4M -9.28M -10.57M -8.6M -9.48M -11.19M -9.8M -7.56M -7.22M -7.26M -7.11M
EBIT
-8.7M -9.99M -8.07M -9.03M -11.27M -4.33M -11.54M -9.62M -9.49M -10.78M -8.8M -9.68M -11.81M -9.95M -7.7M -7.34M -7.39M -7.25M
Depreciation & Amortization
270K 267K 266K 263K 249K 234K 161K 218K 214K 215K 207K 205K 621K 154K 137K 127K 131K 140K